Literature DB >> 32122776

Hyperhomocysteinemia Causes Severe Intraoperative Thrombotic Tendency in Superficial Temporal Artery-middle Cerebral Artery Bypass.

Kei Sato1, Yoichi Morofuji2, Nobutaka Horie2, Tsuyoshi Izumo2, Takeo Anda2, Takayuki Matsuo2.   

Abstract

CASE: Two years ago, annual magnetic resonance imaging for unruptured right internal carotid artery aneurysm of a 47-year-old woman detected a cerebral infarct in her right occipital lobe which was unknown etiology and antiplatelet therapy was initiated. She presented with sensory disorder of her left fingers 4 months ago. Infarction in right parieto-occipital cortex and severe stenosis of right middle cerebral artery was revealed. Her laboratory test was normal except remarkably high homocysteine value. Regardless of dual anti-platelet therapy, she suffered from repeated minor stroke and the stenosis was progressing. Therefore, right superficial temporal artery - middle cerebral artery bypass was undertaken. Aspirin and clopidogrel were withdrawn 1 week before the surgery. Two branches were anastomosed with 2 separate frontal M4 branches. Although patency was confirmed immediately after the anastomosis, thrombus formation was revealed after 10 minutes. We needed to perform removal of the thrombus and re-anastomosis twice. Intraoperative administration of aspirin and ozagrel alleviated thrombotic tendency. After surgery, antiplatelet therapy and supplementation with folate and vitamin B were performed. Her postoperative course was uneventful and patency of both anastomoses was confirmed. DISCUSSION: Controversy still exists regarding preoperative antiplatelet therapy before superficial temporal artery-middle cerebral artery bypass, and folates and B6-12 vitamins supplementation for hyperhomocysteinemia. Considering intraoperative thrombo tendency in our case, it is recommended to evaluate the homocysteine level before bypass surgery for intracranial stenosis especially for young patients or patients with unknown etiology. Before bypass surgery of the patient with hyperhomocysteinemia, continuation of perioperative antiplatelet drugs and supplementation with folates and B6-12 vitamins are mandatory.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Homocysteine; antiplatelet; hyperhomocysteinemia; intracranial stenosis; superficial temporal artery-middle cerebral artery bypass

Year:  2020        PMID: 32122776     DOI: 10.1016/j.jstrokecerebrovasdis.2019.104633

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  3 in total

1.  Hyperhomocysteinemia is a risk factor for postoperative ischemia in adult patients with moyamoya disease.

Authors:  Junsheng Li; Peicong Ge; Qian Zhang; Fa Lin; Rong Wang; Yan Zhang; Dong Zhang; Wen Wang; Jizong Zhao
Journal:  Neurosurg Rev       Date:  2021-01-27       Impact factor: 3.042

2.  Hyperhomocysteinemia Is a Predictor for Poor Postoperative Angiogenesis in Adult Patients With Moyamoya Disease.

Authors:  Qiheng He; Peicong Ge; Xun Ye; Xingju Liu; Jia Wang; Rong Wang; Yan Zhang; Dong Zhang; Jizong Zhao
Journal:  Front Neurol       Date:  2022-06-02       Impact factor: 4.086

3.  Sodium ozagrel and atorvastatin for type 2 diabetes patients with lacunar cerebral infarction.

Authors:  You Yu; Lin Wang; Xu Zhu; Ya-Fei Liu; Hai-Ying Ma
Journal:  World J Diabetes       Date:  2021-12-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.